Submission Details
| 510(k) Number | K212533 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 2021 |
| Decision Date | January 28, 2022 |
| Days to Decision | 170 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
K212533 is an FDA 510(k) clearance for the BLX WB ?5.0 (L18), ?5.5 and ?6.5 mm (L14 and L16) Implants, a Implant, Endosseous, Root-form (Class II — Special Controls, product code DZE), submitted by Institut Straumann AG (Basel, CH). The FDA issued a Cleared decision on January 28, 2022, 170 days after receiving the submission on August 11, 2021. This device falls under the Dental review panel. Regulated under 21 CFR 872.3640.
| 510(k) Number | K212533 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 2021 |
| Decision Date | January 28, 2022 |
| Days to Decision | 170 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
| Product Code | DZE — Implant, Endosseous, Root-form |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 872.3640 |